desoxycorticosterone acetate and prazosin

desoxycorticosterone acetate has been researched along with prazosin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agrawal, N; Gandhi, H; Naik, P; Yadav, M	1
Filipek, B; Kotańska, M; Kubacka, M; Marona, H; Mogilski, S; Nowak, B; Waszkielewicz, AM; Zadrożna, M	1

Other Studies

2 other study(ies) available for desoxycorticosterone acetate and prazosin

Article	Year
Protective effects of MCR-1329, a dual α1 and angII receptor antagonist, in mineralocorticoid-induced hypertension. Pharmacological reports : PR, 2016, Volume: 68, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Chromones; Desoxycorticosterone Acetate; Endothelium, Vascular; Hypertension; Losartan; Male; Mineralocorticoids; Morpholines; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphatidylinositol 3-Kinases; Prazosin; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptors, Angiotensin; Signal Transduction; Vasoconstriction	2016
Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist. Hypertension research : official journal of the Japanese Society of Hypertension, 2019, Volume: 42, Issue:8 Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Desoxycorticosterone Acetate; Drug Evaluation, Preclinical; Endothelium, Vascular; Heart; Heart Rate; Hypertension; Kidney; Lipid Peroxidation; Male; Piperazines; Prazosin; Rats, Wistar	2019

Article

Year

Protective effects of MCR-1329, a dual α1 and angII receptor antagonist, in mineralocorticoid-induced hypertension.

Pharmacological reports : PR, 2016, Volume: 68, Issue:5

Topics: Adrenergic alpha-1 Receptor Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Chromones; Desoxycorticosterone Acetate; Endothelium, Vascular; Hypertension; Losartan; Male; Mineralocorticoids; Morpholines; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphatidylinositol 3-Kinases; Prazosin; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptors, Angiotensin; Signal Transduction; Vasoconstriction

2016

Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist.

Hypertension research : official journal of the Japanese Society of Hypertension, 2019, Volume: 42, Issue:8

Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Desoxycorticosterone Acetate; Drug Evaluation, Preclinical; Endothelium, Vascular; Heart; Heart Rate; Hypertension; Kidney; Lipid Peroxidation; Male; Piperazines; Prazosin; Rats, Wistar

2019